482 related articles for article (PubMed ID: 11956877)
1. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil.
Winters MJ; Hurley RM; Lirenman DS
Pediatr Nephrol; 2002 Apr; 17(4):257-60. PubMed ID: 11956877
[TBL] [Abstract][Full Text] [Related]
2. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
[TBL] [Abstract][Full Text] [Related]
3. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
4. [A case of Grave's disease with MPO-ANCA-associated glomerulonephritis during propylthiouracil (PTU) therapy following interstitial pneumonitis].
Saeki T; Miyamura S; Nakano M; Arakawa M
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):167-71. PubMed ID: 9134835
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
6. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis induced by propylthiouracil (PTU)].
Kato H; Osajima A; Tanaka H; Serino R; Kabashima N; Tamura M; Segawa K; Anai H; Takasugi M; Nakajima Y
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):517-22. PubMed ID: 9283219
[TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.
Kudoh Y; Kuroda S; Shimamoto K; Iimura O
Clin Nephrol; 1997 Jul; 48(1):41-3. PubMed ID: 9247777
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes in patient with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment in Siriraj Hospital.
Visavachaipan N; Ong-Ajyooth L; Chanchairujuira T; Parichatikanond P; Choensuchon B
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S139-46. PubMed ID: 20364568
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
Xu X; Zhao M; Zhang Y; Guo X; Wang H
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
[TBL] [Abstract][Full Text] [Related]
10. [A case of membranous nephropathy with ANCA-associated necrotizing glomerulonephritis during oral administration of PTU for Graves' disease].
Fujii T; Kawamata T; Ueda S; Akikusa B; Hasegawa S; Tsukahara T; Iesato K; Ogawa M; Saisho H
Nihon Jinzo Gakkai Shi; 2003; 45(8):771-7. PubMed ID: 14737995
[TBL] [Abstract][Full Text] [Related]
11. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
13. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.
Yu F; Chen M; Gao Y; Wang SX; Zou WZ; Zhao MH; Wang HY
Am J Kidney Dis; 2007 May; 49(5):607-14. PubMed ID: 17472842
[TBL] [Abstract][Full Text] [Related]
15. [Vasculitis with renal involvement and antineutrophil cytoplasmic antibodies (ANCA) in a child receiving benzylthiouracil].
Hachicha M; Kammoun T; Ben Romdhane W; Ben Abdallah R; Mahfoudh A; Kammoun K; Hachicha J; Triki A
Nephrol Ther; 2007 Jul; 3(4):147-51. PubMed ID: 17658441
[TBL] [Abstract][Full Text] [Related]
16. [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy].
Fujii A; Arimura Y; Minoshima S; Kobayashi M; Yoshihara K; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Takahashi H
Ryumachi; 1997 Dec; 37(6):788-93. PubMed ID: 9492566
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
[TBL] [Abstract][Full Text] [Related]
18. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy.
Yuasa S; Hashimoto M; Yura T; Sumikura T; Takahashi N; Shoji T; Uchida K; Fujioka H; Kihara M; Matsuo H
Nephron; 1996; 73(4):701-3. PubMed ID: 8856275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]